INYT TECHNOLOGIES PRIVATE LIMITED

Business Overview

INYT Technologies Private Limited is the legal entity behind "TABLT" (Tablt Pharmacy), a Kolkata-founded online pharmacy/e-medicine platform delivering medicines, OTC products and healthcare/wellness goods, with a franchise-led last-mile model (~300 franchises) focused on semi-urban and rural Eastern India (West Bengal, Bihar, Jharkhand, Odisha). Founded in 2018 (press reports name co-founders as Anant Jain and "Anish Agarwal" — this does not exactly match the registry director name "Mohendra Agarwal," a discrepancy noted below). In January 2024, Mumbai-based e-pharmacy chain Zeno Health acquired Tablt Pharmacy for an undisclosed sum as part of its expansion into Eastern India (reported by Business Today, Express Pharma, Telegraph India, BioSpectrum India, The Kolkata Mail — multiple independent news outlets agree on the acquisition, though none disclose deal value). Post-acquisition, Tablt's app/brand appears to now run under the Zeno Health corporate umbrella (same app developer "Workcell Solutions Private Limited" powers both the Tablt and Zeno Health apps per the Apple App Store listing). The standalone website tablt.com is no longer resolving (404), consistent with integration into Zeno Health's platform. Company also holds a subsidiary, Sayin Care Private Limited (CIN U51909WB2019PTC231604), per TheCompanyCheck.

Sector & Classification

E-commerce / online healthcare product & pharmaceutical retail (NIC 52609 per CIN prefix — "Other retail trade of pharmaceutical/medical goods"); TheCompanyCheck describes it as "online healthcare product retail," DPIIT-recognised startup

Directors & Key Management

GST Registrations

Primary/home-state GSTIN: 19AAECI9731K1Z2 (West Bengal), registered 5 Oct 2018, status Active, constitution "Private Limited Company," nature of business "Supplier of Services" (source: KnowYourGST individual GSTIN page — confirmed). PAN: AAECI9731K. Total registrations found: 4 across states — 19AAECI9731K1Z2 (West Bengal, home state), 20AAECI9731K1ZJ (Jharkhand), 10AAECI9731K1ZK (Bihar), 21AAECI9731K1ZH (Odisha) — matching the company's stated Eastern-India franchise footprint (WB/Bihar/Jharkhand/Odisha). Individual status confirmed only for the WB GSTIN via KnowYourGST; the other three are corroborated via DuckDuckGo/knowyourgst/gstserver search snippets but not independently opened — partial confirmation.

Financials

Conflicting figures across sources/years — reported as-is, not reconciled: Tofler shows FY ending 31 Mar 2023 (standalone) with revenue in the ₹50–75 crore estimated band, up 74.55% YoY, operating margin 7.48%, net profit margin 6.42%, debt/equity 2.93, ROCE 316.17% (detailed absolute figures paywalled). TheCompanyCheck shows FY ending 31 Mar 2025 revenue of only ₹3 lakh, down ~100% YoY (EBITDA/PAT locked behind paywall); balance sheet date 31 Mar 2025, last AGM 30 Sep 2025, 134 employees as of 22 Nov 2025 (Falconebiz/TheCompanyCheck). The FY23 vs FY25 gap is large but not necessarily contradictory — it is consistent with the Jan 2024 Zeno Health acquisition having moved the operating business/revenue out of this legal entity, leaving INYT Technologies as a near-dormant shell by FY25. Net worth and total borrowings: not obtained (paywalled on both platforms).

Funding History

No standalone VC funding round for INYT Technologies/Tablt was found (Tracxn page repeatedly returned HTTP 429 and could not be opened to check for named rounds). The one confirmed capital event is the Jan 2024 acquisition of Tablt Pharmacy by Zeno Health (undisclosed sum) — reported by Business Today, Express Pharma, Telegraph India, BioSpectrum India, The Kolkata Mail. Zeno Health itself was separately reported to be pursuing a ~$25M Series C around the same period, but that funding belongs to Zeno Health, not to INYT Technologies — kept separate per entity-confusion caution.

Shareholding

Not obtained — Tofler's shareholding-pattern page 404'd and TheCompanyCheck locks shareholding detail behind a paid report. Known shareholders are limited to the two director-shareholders (Anant Jain, Mohendra Agarwal) per Tofler's director listing; exact shareholding percentages not available. No post-acquisition ownership/cap-table change (if any, following the Zeno Health deal) is reflected in any source obtained.

Loans & Charges

No registered charges. Tofler: "As per information available, the company has no registered charges." Falconebiz independently states "Open Charges: None / Secured Borrowings: No charges registered." Confirmed (2 sources agree).

Related Parties

Subsidiary: Sayin Care Private Limited, CIN U51909WB2019PTC231604 (source: TheCompanyCheck; single source, partial). Group/brand context: operates as "TABLT"/"Tablt Pharmacy"; acquired by Zeno Health (Mumbai-based e-pharmacy chain, founded by Siddharth Gadia and Girish Agarwal) in Jan 2024 per multiple press reports — this is a business/brand acquisition as reported in media, not confirmed as a shareholding change in any corporate-registry source obtained, so the corporate-legal relationship between INYT Technologies and Zeno Health is not fully verified.

Credit Ratings

None found. No CRISIL/ICRA/CARE rating surfaced for INYT Technologies or Tablt in registry sources or targeted search.

Legal & Compliance

None found. Indian Kanoon search for "INYT Technologies" returned zero matching case results.

Competitive Landscape

India online-pharmacy/e-medicine peers: Zeno Health (now its acquirer, omnichannel generic-medicine chain), PharmEasy (large national e-pharmacy, much larger scale), Tata 1mg (large, Tata-backed), NetMeds (Reliance-backed, large), Apollo 24|7 (large, hospital-chain backed), Truemeds (mid-size, generics-focused, comparable regional-growth stage). INYT/Tablt was a small regional (Eastern India) franchise-led player relative to these national platforms.

Frequently Asked Questions